Skip to main content
Caplight Logo









Lola Health

Lola Health

Private
LondonHealthcare & Life Scienceshttps://lolahealth.com

Last Round

Accelerator

Jan 5, 2022

Company Overview

Lola Health operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Accelerator round in January 2022.

Lola Health is a health and wellness company that provides at-home blood testing services with professional sample collection and doctor-reviewed results.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, Patient Engagement, E-commerce

Business Model

B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Lola Health Comparables

Compare Lola Health with similar companies based on industry and business-model similarity.

Lola Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ScreenMe
84%
Forth
83%
Medichecks
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Lola Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJan 5, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Lola Health Investors

Notable investors and investment history

Lola Health investors
InvestorRounds
HEC Paris Incubation and Acceleration CenterAccelerator
Platform58Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 5, 2022

    Received funding from HEC Paris and Platform58.

Book a demo to see all signals

For institutional investors. Book with your work email.

Lola Health Filings

Explore SEC and related filing metadata, where available.

Lola Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Lola Health's valuation, stock price, and market status.

Is Lola Health a public or private company?

Lola Health is a private company.

What is the current stock price of Lola Health?

Lola Health is a private company, so its shares have no public market price. Caplight tracks Lola Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Lola Health worth (valuation)?

Valuation information for Lola Health is not publicly available.

Can I buy Lola Health stock?

Lola Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Lola Health's last funding round?

Lola Health's most recent funding round was Accelerator on January 5, 2022.

Who are the main investors in Lola Health?

Key investors in Lola Health include HEC Paris Incubation and Acceleration Center, Platform58.

Will Lola Health IPO soon?

No public IPO plans have been announced for Lola Health.

How can I track Lola Health secondary market activity?

Caplight tracks bids, offers, and trades in Lola Health's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Year FoundedN/A
Last FundingJan 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?